• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC

IMMURON LIMITED - Announcements

2.86% ! 6.8¢
Market Cap $18.23M  !

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



Filters [Clear]
  • Price Sensitive: Yes
IMC IMC Appoints Experienced US Based Biotech Executive as CEOPRICE SENSITIVE19/11/18 download Created with Sketch. 1.08MB
IMC NASH clinical trial presentation & continued revenue growthPRICE SENSITIVE09/11/18 download Created with Sketch. 848.67KB
IMC US DoD Report Travelan Protects Against Shigella in PrimatesPRICE SENSITIVE05/09/18 download Created with Sketch. 1001.92KB
IMC Preliminary Final ReportPRICE SENSITIVE30/08/18 download Created with Sketch. 239.38KB
IMC Immuron Reports Record RevenuePRICE SENSITIVE25/07/18 download Created with Sketch. 872.69KB
IMC US Department of Defense Research Collaboration Moves AheadPRICE SENSITIVE16/07/18 download Created with Sketch. 881.93KB
IMC European Patent Gramted for Nash TreatmentPRICE SENSITIVE11/07/18 download Created with Sketch. 782.89KB
IMC Immuron Announces Board AppointmentPRICE SENSITIVE26/06/18 download Created with Sketch. 815.87KB
IMC Trading HaltPRICE SENSITIVE25/06/18 download Created with Sketch. 221.37KB
IMC IMC Preclinical Study Reports Reduction in Colitis SymptomsPRICE SENSITIVE08/05/18 download Created with Sketch. 960.7KB
IMC Travelan Sales Continue to Soar in Third Quarter of FY2018PRICE SENSITIVE23/04/18 download Created with Sketch. 369.02KB
IMC Immuron Announces A$5.1M Private Placement to U.S. FundPRICE SENSITIVE14/03/18 download Created with Sketch. 362.89KB
IMC Immuron Progresses Discussions with Institutional FundsPRICE SENSITIVE13/03/18 download Created with Sketch. 349.77KB
IMC Trading HaltPRICE SENSITIVE12/03/18 download Created with Sketch. 215.65KB
IMC Immuron Reports Positive Results in NASH Clinical TrialPRICE SENSITIVE08/03/18 download Created with Sketch. 402.23KB
IMC Correction to False and Misleading News ReleasePRICE SENSITIVE07/03/18 download Created with Sketch. 362.45KB
IMC Trading HaltPRICE SENSITIVE07/03/18 download Created with Sketch. 300.18KB
IMC Appendix 4D - Half Year Financial Report - 31 Dec 2017PRICE SENSITIVE28/02/18 download Created with Sketch. 261.97KB
IMC Travelan Revenue Grows Significantly in US and AustraliaPRICE SENSITIVE16/02/18 download Created with Sketch. 355.64KB
IMC US Defence Depart Report-Travelan Targets Priority PathogensPRICE SENSITIVE30/01/18 download Created with Sketch. 119.7KB
IMC Immuron to Receive $2.16M R&D Tax Concession Cash RefundPRICE SENSITIVE23/01/18 download Created with Sketch. 348.51KB
IMC Immuron Granted US Patent for NASH TreatmentPRICE SENSITIVE14/11/17 download Created with Sketch. 213.3KB
IMC Immuron Successfully Completes NASH Phase II Clinical StudyPRICE SENSITIVE09/11/17 download Created with Sketch. 218.35KB
IMC Travelan Experiences Strong Q1 FY2018 Sales GrowthPRICE SENSITIVE08/11/17 download Created with Sketch. 333.17KB
IMC Appendix 4E Preliminary Final Report (30 June 2017)PRICE SENSITIVE31/08/17 download Created with Sketch. 1.04MB
IMC Immuron Opens Clinical Site to Commence C.Diff CDI StudyPRICE SENSITIVE28/08/17 download Created with Sketch. 959.09KB
IMC Immuron Approved to Commence Clinical Study in C.DifficilePRICE SENSITIVE09/08/17 download Created with Sketch. 118.99KB
IMC Immuron to Present C.difficile Data at ClostPath 2017 ConferPRICE SENSITIVE08/08/17 download Created with Sketch. 354.02KB
IMC Immuron Announces Management ChangesPRICE SENSITIVE03/08/17 download Created with Sketch. 336.18KB
IMC Success of NASH Phase II Interim Analysis Explained FurtherPRICE SENSITIVE13/07/17 download Created with Sketch. 371.05KB
IMC NASH PhaseII Interim Analysis Reveals Improved Liver EnzymesPRICE SENSITIVE10/07/17 download Created with Sketch. 347.54KB
IMC Pre-Clinical C. difficile Infection Results Paper PublishedPRICE SENSITIVE03/07/17 download Created with Sketch. 353.77KB
IMC IMC Prices US IPO and NASDAQ Listing Raising USD$6.1MPRICE SENSITIVE09/06/17 download Created with Sketch. 1.11MB
IMC Trading HaltPRICE SENSITIVE08/06/17 download Created with Sketch. 297.21KB
IMC Travelan Increases Industry Presence - Conf & Sales UpdatePRICE SENSITIVE02/06/17 download Created with Sketch. 1.12MB
IMC Immuron Secures $1.5M R&D Cash Advance Loan FundingPRICE SENSITIVE01/06/17 download Created with Sketch. 1.09MB
IMC NASDAQ Listing on Hold Pending NASH Interim Analysis ResultsPRICE SENSITIVE01/06/17 download Created with Sketch. 1.09MB
IMC Trading HaltPRICE SENSITIVE30/05/17 download Created with Sketch. 297.07KB
IMC IMC Expands Agreement with US Army-3 Additional TherapeuticsPRICE SENSITIVE16/05/17 download Created with Sketch. 1.11MB
IMC Completion of Manufacturing of Drug Product for C-Diff TrialPRICE SENSITIVE10/05/17 download Created with Sketch. 1.11MB
IMC IMC Form F1 - US Registration Statement (Prelim. Prospectus)PRICE SENSITIVE09/05/17 download Created with Sketch. 1MB
IMC Positive Results of IMM-124E in Acute Colitis StudiesPRICE SENSITIVE18/04/17 download Created with Sketch. 1.23MB
IMC Close of Recruitment of Phase II NASH TrialPRICE SENSITIVE06/04/17 download Created with Sketch. 426.2KB
IMC Appendix 4D - Half Year Report and Accounts - Dec 2016PRICE SENSITIVE28/02/17 download Created with Sketch. 1.22MB
IMC Immuron Completes Phase II NASH Clinical Trial RecruitmentPRICE SENSITIVE20/02/17 download Created with Sketch. 1.08MB
IMC First Patient in Pediatric Fatty-Liver Phase II TrialPRICE SENSITIVE06/02/17 download Created with Sketch. 432.48KB
IMC NASH MOA Study commences with SanyalBio & Duke UniversityPRICE SENSITIVE19/01/17 download Created with Sketch. 464.37KB
IMC Immuron Receives $1.6M R&D Tax Concession RefundPRICE SENSITIVE29/11/16 download Created with Sketch. 87.12KB
IMC Immurons NASH Phase II Trial Achieves 100 Patient Milestone-IMC.AX PRICE SENSITIVE28/10/16 download Created with Sketch. 108.59KB
IMC NASH Phase II Trial reaches 75% of Patient Recruitment-IMC.AX PRICE SENSITIVE10/10/16 download Created with Sketch. 112.49KB
IMC Immurons $6M Rights Issue Closes Oversubscribed-IMC.AX PRICE SENSITIVE04/10/16 download Created with Sketch. 98.8KB
IMC Appendix 4E and Annual Report-IMC.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 2.09MB
IMC Immuron Expands Collaborate with US Navy-IMC.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 467.6KB
IMC US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH-IMC.AX PRICE SENSITIVE18/08/16 download Created with Sketch. 119.14KB
IMC Travelan to be Stocked by US Distributor Medique Products-IMC.AX PRICE SENSITIVE08/08/16 download Created with Sketch. 99.33KB
IMC Immuron to Cooperate with Universities on Autism Research-IMC.AX PRICE SENSITIVE20/07/16 download Created with Sketch. 453.37KB
IMC Immuron to repay outstanding Convertible Note in cash-IMC.AX PRICE SENSITIVE18/07/16 download Created with Sketch. 97.72KB
IMC IMC Signs Shigella Vaccine Developmt Agreement with US Army-IMC.AX PRICE SENSITIVE21/06/16 download Created with Sketch. 103.13KB
IMC Travelan and Protectyn Are Now Available For Sale in China-IMC.AX PRICE SENSITIVE16/06/16 download Created with Sketch. 313.17KB
IMC Travelan to Reach Upto 1.5M New US Customers via Magellans-IMC.AX PRICE SENSITIVE14/06/16 download Created with Sketch. 92.21KB
IMC Immuron Rights Issue Offer Booklet (May 2016)-IMC.AX PRICE SENSITIVE31/05/16 download Created with Sketch. 315.95KB
IMC Immuron Announces $6M Rights Issue Offer-IMC.AX PRICE SENSITIVE31/05/16 download Created with Sketch. 140.58KB
IMC Trading halt-IMC.AX PRICE SENSITIVE27/05/16 download Created with Sketch. 133.42KB
IMC NASH Phase II Trial Reaches 50% Recruitment Milestone-IMC.AX PRICE SENSITIVE25/05/16 download Created with Sketch. 92.52KB
IMC Immuron Announces E-Commerce Agreement with QBID in China-IMC.AX PRICE SENSITIVE09/05/16 download Created with Sketch. 114.05KB
IMC US Distribution Reach Expanded through McKesson-IMC.AX PRICE SENSITIVE28/04/16 download Created with Sketch. 403.5KB
IMC US Travelan Sales Network Widened by Allocation Inc Ptnrship-IMC.AX PRICE SENSITIVE19/04/16 download Created with Sketch. 105.28KB
IMC Expansion of US Travelan Sales Following CVS Pharmacy Launch-IMC.AX PRICE SENSITIVE14/04/16 download Created with Sketch. 102.8KB
IMC Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE25/02/16 download Created with Sketch. 1.67MB
IMC Immuron Initiates Pre-Clinical Colitis Development ProgramPRICE SENSITIVE22/02/16 download Created with Sketch. 100.49KB
IMC Immuron Secures upto $1.7M Equity & Convertible Note FundingPRICE SENSITIVE17/02/16 download Created with Sketch. 99.71KB
IMC Immuron Receives $1.47M R&D Tax Concession RefundPRICE SENSITIVE04/02/16 download Created with Sketch. 83.71KB
IMC Analyst Reports on Immuron IMM-529 C. difficile ProgramPRICE SENSITIVE14/01/16 download Created with Sketch. 89.67KB
IMC IMC Achieves Outstanding Results in C-Diff Recurrence StudyPRICE SENSITIVE12/01/16 download Created with Sketch. 116.44KB
IMC IMC Reports Highly Successful C-Diff Pre-Clinical ResultsPRICE SENSITIVE22/12/15 download Created with Sketch. 115.8KB
IMC NASH Clinical Trial Surpasses 25% Patient Recruitment LevelPRICE SENSITIVE18/11/15 download Created with Sketch. 95.33KB
IMC IMC Signs US Travelan Sales Agreement with Medico-Mart IncPRICE SENSITIVE12/11/15 download Created with Sketch. 90.51KB
IMC NASH Diagnostic Collaboration Agreement - OWL MetabolomicsPRICE SENSITIVE09/11/15 download Created with Sketch. 104.29KB
IMC Passport Health - Sales Partnership AgreementPRICE SENSITIVE26/10/15 download Created with Sketch. 307.82KB
IMC Appendix 4E Preliminary Final Report & Annual ReportPRICE SENSITIVE28/08/15 download Created with Sketch. 3.5MB
IMC Immuron Appoints New Chief Executive OfficerPRICE SENSITIVE25/08/15 download Created with Sketch. 95.52KB
IMC Proposed Issue of Unlisted OptionsPRICE SENSITIVE06/08/15 download Created with Sketch. 70.16KB
IMC Immuron Executes Major US Travelan Sales AgreementPRICE SENSITIVE04/08/15 download Created with Sketch. 99.83KB
IMC Resignation of Chief Executive OfficerPRICE SENSITIVE08/07/15 download Created with Sketch. 82.13KB
IMC NASH Clinical Trial Update - Patient Recruitment AdvancesPRICE SENSITIVE02/07/15 download Created with Sketch. 90.52KB
IMC IMMURON ANNOUNCES FIRST USA ORDERS FOR TRAVELANPRICE SENSITIVE20/04/15 download Created with Sketch. 102.54KB
IMC Immuron Appoints Dr. Leearne Hinch as New CEOPRICE SENSITIVE02/04/15 download Created with Sketch. 74.35KB
IMC Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE18/02/15 download Created with Sketch. 765.31KB
IMC Marketing and Distribution Agreement signed for ChinaPRICE SENSITIVE17/02/15 download Created with Sketch. 82.72KB
IMC Patient Recruitment Commenced for Phase 2 NASH TrialPRICE SENSITIVE03/02/15 download Created with Sketch. 98.72KB
IMC IMC signs License Agreement for Development for Alcohol ToxPRICE SENSITIVE06/01/15 download Created with Sketch. 78.39KB
IMC Resignation of CEOPRICE SENSITIVE18/12/14 download Created with Sketch. 80.47KB
IMC Immuron Completes Capital ConsolidationPRICE SENSITIVE20/11/14 download Created with Sketch. 86.3KB
IMC NASH & ASH Clinical Trial UpdatePRICE SENSITIVE15/10/14 download Created with Sketch. 128.94KB
IMC Immuron Improves Hadasit Royalty TermsPRICE SENSITIVE02/09/14 download Created with Sketch. 73.79KB
IMC Appendix 4E Preliminary Final Report and Statutory AccountsPRICE SENSITIVE29/08/14 download Created with Sketch. 2.36MB
IMC Paladin Labs Announces the Launch of Travelan in CanadaPRICE SENSITIVE06/08/14 download Created with Sketch. 416.14KB
IMC Immuron FY2014 Travelan Sales Exceed $1mPRICE SENSITIVE07/07/14 download Created with Sketch. 75.14KB
IMCImmuron Signs Agreement to Sell Travelan in South KoreaPRICE SENSITIVE21/05/14 download Created with Sketch. 119.38KB
IMCImmuron Extinguishes Paladin DebtPRICE SENSITIVE05/05/14 download Created with Sketch. 71.94KB
IMC IMC Appoints Experienced US Based Biotech Executive as CEO
19/11/18PRICE SENSITIVE download Created with Sketch. 1.08MB
IMC NASH clinical trial presentation & continued revenue growth
09/11/18PRICE SENSITIVE download Created with Sketch. 848.67KB
IMC US DoD Report Travelan Protects Against Shigella in Primates
05/09/18PRICE SENSITIVE download Created with Sketch. 1001.92KB
IMC Preliminary Final Report
30/08/18PRICE SENSITIVE download Created with Sketch. 239.38KB
IMC Immuron Reports Record Revenue
25/07/18PRICE SENSITIVE download Created with Sketch. 872.69KB
IMC US Department of Defense Research Collaboration Moves Ahead
16/07/18PRICE SENSITIVE download Created with Sketch. 881.93KB
IMC European Patent Gramted for Nash Treatment
11/07/18PRICE SENSITIVE download Created with Sketch. 782.89KB
IMC Immuron Announces Board Appointment
26/06/18PRICE SENSITIVE download Created with Sketch. 815.87KB
IMC Trading Halt
25/06/18PRICE SENSITIVE download Created with Sketch. 221.37KB
IMC IMC Preclinical Study Reports Reduction in Colitis Symptoms
08/05/18PRICE SENSITIVE download Created with Sketch. 960.7KB
IMC Travelan Sales Continue to Soar in Third Quarter of FY2018
23/04/18PRICE SENSITIVE download Created with Sketch. 369.02KB
IMC Immuron Announces A$5.1M Private Placement to U.S. Fund
14/03/18PRICE SENSITIVE download Created with Sketch. 362.89KB
IMC Immuron Progresses Discussions with Institutional Funds
13/03/18PRICE SENSITIVE download Created with Sketch. 349.77KB
IMC Trading Halt
12/03/18PRICE SENSITIVE download Created with Sketch. 215.65KB
IMC Immuron Reports Positive Results in NASH Clinical Trial
08/03/18PRICE SENSITIVE download Created with Sketch. 402.23KB
IMC Correction to False and Misleading News Release
07/03/18PRICE SENSITIVE download Created with Sketch. 362.45KB
IMC Trading Halt
07/03/18PRICE SENSITIVE download Created with Sketch. 300.18KB
IMC Appendix 4D - Half Year Financial Report - 31 Dec 2017
28/02/18PRICE SENSITIVE download Created with Sketch. 261.97KB
IMC Travelan Revenue Grows Significantly in US and Australia
16/02/18PRICE SENSITIVE download Created with Sketch. 355.64KB
IMC US Defence Depart Report-Travelan Targets Priority Pathogens
30/01/18PRICE SENSITIVE download Created with Sketch. 119.7KB
IMC Immuron to Receive $2.16M R&D Tax Concession Cash Refund
23/01/18PRICE SENSITIVE download Created with Sketch. 348.51KB
IMC Immuron Granted US Patent for NASH Treatment
14/11/17PRICE SENSITIVE download Created with Sketch. 213.3KB
IMC Immuron Successfully Completes NASH Phase II Clinical Study
09/11/17PRICE SENSITIVE download Created with Sketch. 218.35KB
IMC Travelan Experiences Strong Q1 FY2018 Sales Growth
08/11/17PRICE SENSITIVE download Created with Sketch. 333.17KB
IMC Appendix 4E Preliminary Final Report (30 June 2017)
31/08/17PRICE SENSITIVE download Created with Sketch. 1.04MB
IMC Immuron Opens Clinical Site to Commence C.Diff CDI Study
28/08/17PRICE SENSITIVE download Created with Sketch. 959.09KB
IMC Immuron Approved to Commence Clinical Study in C.Difficile
09/08/17PRICE SENSITIVE download Created with Sketch. 118.99KB
IMC Immuron to Present C.difficile Data at ClostPath 2017 Confer
08/08/17PRICE SENSITIVE download Created with Sketch. 354.02KB
IMC Immuron Announces Management Changes
03/08/17PRICE SENSITIVE download Created with Sketch. 336.18KB
IMC Success of NASH Phase II Interim Analysis Explained Further
13/07/17PRICE SENSITIVE download Created with Sketch. 371.05KB
IMC NASH PhaseII Interim Analysis Reveals Improved Liver Enzymes
10/07/17PRICE SENSITIVE download Created with Sketch. 347.54KB
IMC Pre-Clinical C. difficile Infection Results Paper Published
03/07/17PRICE SENSITIVE download Created with Sketch. 353.77KB
IMC IMC Prices US IPO and NASDAQ Listing Raising USD$6.1M
09/06/17PRICE SENSITIVE download Created with Sketch. 1.11MB
IMC Trading Halt
08/06/17PRICE SENSITIVE download Created with Sketch. 297.21KB
IMC Travelan Increases Industry Presence - Conf & Sales Update
02/06/17PRICE SENSITIVE download Created with Sketch. 1.12MB
IMC Immuron Secures $1.5M R&D Cash Advance Loan Funding
01/06/17PRICE SENSITIVE download Created with Sketch. 1.09MB
IMC NASDAQ Listing on Hold Pending NASH Interim Analysis Results
01/06/17PRICE SENSITIVE download Created with Sketch. 1.09MB
IMC Trading Halt
30/05/17PRICE SENSITIVE download Created with Sketch. 297.07KB
IMC IMC Expands Agreement with US Army-3 Additional Therapeutics
16/05/17PRICE SENSITIVE download Created with Sketch. 1.11MB
IMC Completion of Manufacturing of Drug Product for C-Diff Trial
10/05/17PRICE SENSITIVE download Created with Sketch. 1.11MB
IMC IMC Form F1 - US Registration Statement (Prelim. Prospectus)
09/05/17PRICE SENSITIVE download Created with Sketch. 1MB
IMC Positive Results of IMM-124E in Acute Colitis Studies
18/04/17PRICE SENSITIVE download Created with Sketch. 1.23MB
IMC Close of Recruitment of Phase II NASH Trial
06/04/17PRICE SENSITIVE download Created with Sketch. 426.2KB
IMC Appendix 4D - Half Year Report and Accounts - Dec 2016
28/02/17PRICE SENSITIVE download Created with Sketch. 1.22MB
IMC Immuron Completes Phase II NASH Clinical Trial Recruitment
20/02/17PRICE SENSITIVE download Created with Sketch. 1.08MB
IMC First Patient in Pediatric Fatty-Liver Phase II Trial
06/02/17PRICE SENSITIVE download Created with Sketch. 432.48KB
IMC NASH MOA Study commences with SanyalBio & Duke University
19/01/17PRICE SENSITIVE download Created with Sketch. 464.37KB
IMC Immuron Receives $1.6M R&D Tax Concession Refund
29/11/16PRICE SENSITIVE download Created with Sketch. 87.12KB
IMC Immurons NASH Phase II Trial Achieves 100 Patient Milestone-IMC.AX
28/10/16PRICE SENSITIVE download Created with Sketch. 108.59KB
IMC NASH Phase II Trial reaches 75% of Patient Recruitment-IMC.AX
10/10/16PRICE SENSITIVE download Created with Sketch. 112.49KB
IMC Immurons $6M Rights Issue Closes Oversubscribed-IMC.AX
04/10/16PRICE SENSITIVE download Created with Sketch. 98.8KB
IMC Appendix 4E and Annual Report-IMC.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 2.09MB
IMC Immuron Expands Collaborate with US Navy-IMC.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 467.6KB
IMC US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH-IMC.AX
18/08/16PRICE SENSITIVE download Created with Sketch. 119.14KB
IMC Travelan to be Stocked by US Distributor Medique Products-IMC.AX
08/08/16PRICE SENSITIVE download Created with Sketch. 99.33KB
IMC Immuron to Cooperate with Universities on Autism Research-IMC.AX
20/07/16PRICE SENSITIVE download Created with Sketch. 453.37KB
IMC Immuron to repay outstanding Convertible Note in cash-IMC.AX
18/07/16PRICE SENSITIVE download Created with Sketch. 97.72KB
IMC IMC Signs Shigella Vaccine Developmt Agreement with US Army-IMC.AX
21/06/16PRICE SENSITIVE download Created with Sketch. 103.13KB
IMC Travelan and Protectyn Are Now Available For Sale in China-IMC.AX
16/06/16PRICE SENSITIVE download Created with Sketch. 313.17KB
IMC Travelan to Reach Upto 1.5M New US Customers via Magellans-IMC.AX
14/06/16PRICE SENSITIVE download Created with Sketch. 92.21KB
IMC Immuron Rights Issue Offer Booklet (May 2016)-IMC.AX
31/05/16PRICE SENSITIVE download Created with Sketch. 315.95KB
IMC Immuron Announces $6M Rights Issue Offer-IMC.AX
31/05/16PRICE SENSITIVE download Created with Sketch. 140.58KB
IMC Trading halt-IMC.AX
27/05/16PRICE SENSITIVE download Created with Sketch. 133.42KB
IMC NASH Phase II Trial Reaches 50% Recruitment Milestone-IMC.AX
25/05/16PRICE SENSITIVE download Created with Sketch. 92.52KB
IMC Immuron Announces E-Commerce Agreement with QBID in China-IMC.AX
09/05/16PRICE SENSITIVE download Created with Sketch. 114.05KB
IMC US Distribution Reach Expanded through McKesson-IMC.AX
28/04/16PRICE SENSITIVE download Created with Sketch. 403.5KB
IMC US Travelan Sales Network Widened by Allocation Inc Ptnrship-IMC.AX
19/04/16PRICE SENSITIVE download Created with Sketch. 105.28KB
IMC Expansion of US Travelan Sales Following CVS Pharmacy Launch-IMC.AX
14/04/16PRICE SENSITIVE download Created with Sketch. 102.8KB
IMC Appendix 4D - Half Yearly Report and Accounts
25/02/16PRICE SENSITIVE download Created with Sketch. 1.67MB
IMC Immuron Initiates Pre-Clinical Colitis Development Program
22/02/16PRICE SENSITIVE download Created with Sketch. 100.49KB
IMC Immuron Secures upto $1.7M Equity & Convertible Note Funding
17/02/16PRICE SENSITIVE download Created with Sketch. 99.71KB
IMC Immuron Receives $1.47M R&D Tax Concession Refund
04/02/16PRICE SENSITIVE download Created with Sketch. 83.71KB
IMC Analyst Reports on Immuron IMM-529 C. difficile Program
14/01/16PRICE SENSITIVE download Created with Sketch. 89.67KB
IMC IMC Achieves Outstanding Results in C-Diff Recurrence Study
12/01/16PRICE SENSITIVE download Created with Sketch. 116.44KB
IMC IMC Reports Highly Successful C-Diff Pre-Clinical Results
22/12/15PRICE SENSITIVE download Created with Sketch. 115.8KB
IMC NASH Clinical Trial Surpasses 25% Patient Recruitment Level
18/11/15PRICE SENSITIVE download Created with Sketch. 95.33KB
IMC IMC Signs US Travelan Sales Agreement with Medico-Mart Inc
12/11/15PRICE SENSITIVE download Created with Sketch. 90.51KB
IMC NASH Diagnostic Collaboration Agreement - OWL Metabolomics
09/11/15PRICE SENSITIVE download Created with Sketch. 104.29KB
IMC Passport Health - Sales Partnership Agreement
26/10/15PRICE SENSITIVE download Created with Sketch. 307.82KB
IMC Appendix 4E Preliminary Final Report & Annual Report
28/08/15PRICE SENSITIVE download Created with Sketch. 3.5MB
IMC Immuron Appoints New Chief Executive Officer
25/08/15PRICE SENSITIVE download Created with Sketch. 95.52KB
IMC Proposed Issue of Unlisted Options
06/08/15PRICE SENSITIVE download Created with Sketch. 70.16KB
IMC Immuron Executes Major US Travelan Sales Agreement
04/08/15PRICE SENSITIVE download Created with Sketch. 99.83KB
IMC Resignation of Chief Executive Officer
08/07/15PRICE SENSITIVE download Created with Sketch. 82.13KB
IMC NASH Clinical Trial Update - Patient Recruitment Advances
02/07/15PRICE SENSITIVE download Created with Sketch. 90.52KB
IMC IMMURON ANNOUNCES FIRST USA ORDERS FOR TRAVELAN
20/04/15PRICE SENSITIVE download Created with Sketch. 102.54KB
IMC Immuron Appoints Dr. Leearne Hinch as New CEO
02/04/15PRICE SENSITIVE download Created with Sketch. 74.35KB
IMC Appendix 4D - Half Yearly Report and Accounts
18/02/15PRICE SENSITIVE download Created with Sketch. 765.31KB
IMC Marketing and Distribution Agreement signed for China
17/02/15PRICE SENSITIVE download Created with Sketch. 82.72KB
IMC Patient Recruitment Commenced for Phase 2 NASH Trial
03/02/15PRICE SENSITIVE download Created with Sketch. 98.72KB
IMC IMC signs License Agreement for Development for Alcohol Tox
06/01/15PRICE SENSITIVE download Created with Sketch. 78.39KB
IMC Resignation of CEO
18/12/14PRICE SENSITIVE download Created with Sketch. 80.47KB
IMC Immuron Completes Capital Consolidation
20/11/14PRICE SENSITIVE download Created with Sketch. 86.3KB
IMC NASH & ASH Clinical Trial Update
15/10/14PRICE SENSITIVE download Created with Sketch. 128.94KB
IMC Immuron Improves Hadasit Royalty Terms
02/09/14PRICE SENSITIVE download Created with Sketch. 73.79KB
IMC Appendix 4E Preliminary Final Report and Statutory Accounts
29/08/14PRICE SENSITIVE download Created with Sketch. 2.36MB
IMC Paladin Labs Announces the Launch of Travelan in Canada
06/08/14PRICE SENSITIVE download Created with Sketch. 416.14KB
IMC Immuron FY2014 Travelan Sales Exceed $1m
07/07/14PRICE SENSITIVE download Created with Sketch. 75.14KB
IMCImmuron Signs Agreement to Sell Travelan in South Korea
21/05/14PRICE SENSITIVE download Created with Sketch. 119.38KB
IMCImmuron Extinguishes Paladin Debt
05/05/14PRICE SENSITIVE download Created with Sketch. 71.94KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.8¢
Change
-0.002(2.86%)
Mkt cap ! $18.23M
Open High Low Value Volume
7.0¢ 7.0¢ 6.8¢ $7.191K 103.4K

Buyers (Bids)

No. Vol. Price($)
2 10000 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 148418 1
View Market Depth
Last trade - 16.10pm 09/09/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.